XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning Balances (in shares) at Dec. 31, 2021   26,553,508      
Beginning Balances at Dec. 31, 2021 $ 668,459 $ 26,554 $ 276,057 $ 350,364 $ 15,484
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 9,067     9,067  
Other Comprehensive Income (Loss) (133,885)       (133,885)
Cash Dividends (6,752)     (6,752)  
Issuance of Common Stock for:          
Acquisition of Citizens Union Bancorp of Shelbyville, Inc., net (in shares)   2,870,975      
Acquisition of Citizens Union Bancorp of Shelbyville, Inc., net 111,723 $ 2,871 108,852    
Restricted Share Grants Net (in shares)   61,200      
Restricted Share Grants Net 424 $ 61 363    
Ending Balances (in shares) at Mar. 31, 2022   29,485,683      
Ending Balances at Mar. 31, 2022 649,036 $ 29,486 385,272 352,679 (118,401)
Beginning Balances (in shares) at Dec. 31, 2021   26,553,508      
Beginning Balances at Dec. 31, 2021 668,459 $ 26,554 276,057 350,364 15,484
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 57,410        
Other Comprehensive Income (Loss) (324,542)        
Ending Balances (in shares) at Sep. 30, 2022   29,485,121      
Ending Balances at Sep. 30, 2022 494,701 $ 29,485 386,764 387,510 (309,058)
Beginning Balances (in shares) at Mar. 31, 2022   29,485,683      
Beginning Balances at Mar. 31, 2022 649,036 $ 29,486 385,272 352,679 (118,401)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 23,747     23,747  
Other Comprehensive Income (Loss) (92,694)       (92,694)
Cash Dividends (6,753)     (6,753)  
Issuance of Common Stock for:          
Restricted Share Grants Net (in shares)   (2,638)      
Restricted Share Grants Net 1,093 $ (3) 1,096    
Ending Balances (in shares) at Jun. 30, 2022   29,483,045      
Ending Balances at Jun. 30, 2022 574,429 $ 29,483 386,368 369,673 (211,095)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 24,596     24,596  
Other Comprehensive Income (Loss) (97,963)       (97,963)
Cash Dividends (6,759)     (6,759)  
Issuance of Common Stock for:          
Restricted Share Grants Net (in shares)   2,076      
Restricted Share Grants Net 398 $ 2 396    
Ending Balances (in shares) at Sep. 30, 2022   29,485,121      
Ending Balances at Sep. 30, 2022 $ 494,701 $ 29,485 386,764 387,510 (309,058)
Beginning Balances (in shares) at Dec. 31, 2022 29,493,193 29,493,193      
Beginning Balances at Dec. 31, 2022 $ 558,393 $ 29,493 387,171 405,167 (263,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 20,807     20,807  
Other Comprehensive Income (Loss) 32,946       32,946
Cash Dividends (7,354)     (7,354)  
Issuance of Common Stock for:          
Restricted Share Grants Net (in shares)   80,246      
Restricted Share Grants Net 539 $ 80 459    
Ending Balances (in shares) at Mar. 31, 2023   29,573,439      
Ending Balances at Mar. 31, 2023 $ 605,331 $ 29,573 387,630 418,620 (230,492)
Beginning Balances (in shares) at Dec. 31, 2022 29,493,193 29,493,193      
Beginning Balances at Dec. 31, 2022 $ 558,393 $ 29,493 387,171 405,167 (263,438)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 64,381        
Other Comprehensive Income (Loss) $ (64,175)        
Ending Balances (in shares) at Sep. 30, 2023 29,575,451 29,575,451      
Ending Balances at Sep. 30, 2023 $ 538,392 $ 29,575 388,955 447,475 (327,613)
Beginning Balances (in shares) at Mar. 31, 2023   29,573,439      
Beginning Balances at Mar. 31, 2023 605,331 $ 29,573 387,630 418,620 (230,492)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 22,123     22,123  
Other Comprehensive Income (Loss) (18,360)       (18,360)
Cash Dividends (7,359)     (7,359)  
Issuance of Common Stock for:          
Restricted Share Grants Net (in shares)   (656)      
Restricted Share Grants Net 830   830    
Ending Balances (in shares) at Jun. 30, 2023   29,572,783      
Ending Balances at Jun. 30, 2023 602,565 $ 29,573 388,460 433,384 (248,852)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net Income 21,451     21,451  
Other Comprehensive Income (Loss) (78,761)       (78,761)
Cash Dividends (7,360)     (7,360)  
Issuance of Common Stock for:          
Restricted Share Grants Net (in shares)   2,668      
Restricted Share Grants Net $ 497 $ 2 495    
Ending Balances (in shares) at Sep. 30, 2023 29,575,451 29,575,451      
Ending Balances at Sep. 30, 2023 $ 538,392 $ 29,575 $ 388,955 $ 447,475 $ (327,613)